Subsets of glioblastoma: clinical and histological vs. genetic typing
- PMID: 9804375
- PMCID: PMC8098438
- DOI: 10.1111/j.1750-3639.1998.tb00192.x
Subsets of glioblastoma: clinical and histological vs. genetic typing
Comment on
-
Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes.Brain Pathol. 1998 Oct;8(4):655-67. doi: 10.1111/j.1750-3639.1998.tb00191.x. Brain Pathol. 1998. PMID: 9804374 Free PMC article. Clinical Trial.
References
-
- Kleihues P , Ohgaki H. ( 1997. ) Genetics of glioma progression and the definition of primary and secondary glioblastomas . Brain Pathol 7 : 1131 – 1136 .
-
- Lang FF , Miller DC , Koslow M , Newcomb EW. ( 1994. ) Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors . J Neurosurg 81 : 427 – 436 . - PubMed
-
- Louis DN , Gusella JF. ( 1995. ) A tiger behind many doors: multiple genetic pathways to maligant glioma . TIG 11 : 412 – 415 . - PubMed
-
- Ohgaki H , Watanabe K , Peraud A , Nakazato Y , von Deimling A. ( 1997. ) Giant cell glioblastomas . In : Pathology and Genetics of Tumours of the Nervous System , Kleihues P , Cavenee WK , ( Eds ), pp. 25 – 26 , International Agency for Research on Cancer; : Lyon .
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
